These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3459265)

  • 1. Structural requirements for inducing cardiotoxicity by anthracycline antibiotics: studies with neonatal rat cardiac myocytes in culture.
    Shirhatti V; George M; Chenery R; Krishna G
    Toxicol Appl Pharmacol; 1986 Jun; 84(1):173-91. PubMed ID: 3459265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios.
    Dorr RT; Bozak KA; Shipp NG; Hendrix M; Alberts DS; Ahmann F
    Cancer Res; 1988 Sep; 48(18):5222-7. PubMed ID: 3409247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
    Singh Y; Ulrich L; Katz D; Bowen P; Krishna G
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):9-23. PubMed ID: 2763305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro.
    Dorr RT; Shipp NG; Lee KM
    Anticancer Drugs; 1991 Feb; 2(1):27-33. PubMed ID: 1958848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
    Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
    Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
    Taylor AL; Applefeld MM; Wiernik PH; Grochow LB; Mader LC; Bulkley BH
    Cancer; 1984 Apr; 53(8):1660-6. PubMed ID: 6582997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium protection against anthracycline toxicity in vitro.
    Zdanowicz MM; Barletta MA
    Magnes Res; 1991 Jun; 4(2):105-7. PubMed ID: 1911091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daunomycin inhibits the uptake of adenine, amino acids, and glucose into cardiac myocytes.
    Reese JB; Shirhatti V; Singh Y; Krishna G
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):105-12. PubMed ID: 3564026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat.
    Cini Neri G; Neri B; Bandinelli M; Del Tacca M; Danesi R; Riccardi R
    Oncology; 1991; 48(4):327-33. PubMed ID: 1891176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture.
    DeAtley SM; Aksenov MY; Aksenova MV; Jordan B; Carney JM; Butterfield DA
    Toxicology; 1999 May; 134(1):51-62. PubMed ID: 10413188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell cultures.
    Julicher RH; van der Laarse A; Sterrenberg L; Bloys van Treslong CH; Bast A; Noordhoek J
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):35-47. PubMed ID: 3983469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture.
    Hershko C; Link G; Tzahor M; Kaltwasser JP; Athias P; Grynberg A; Pinson A
    J Lab Clin Med; 1993 Sep; 122(3):245-51. PubMed ID: 8409700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple and sensitive method for monitoring drug-induced cell injury in cultured cells.
    Shirhatti V; Krishna G
    Anal Biochem; 1985 Jun; 147(2):410-8. PubMed ID: 4014685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-actin synthesis changes in cultured cardiac myocytes: relationship to anthracycline structure.
    Lewis W; Perillo NL; Gonzalez B
    J Lab Clin Med; 1988 Jul; 112(1):43-51. PubMed ID: 3164748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicity.
    Vora J; Boroujerdi M
    J Pharm Pharmacol; 1996 Dec; 48(12):1264-9. PubMed ID: 9004189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity.
    Fink SI; Leo A; Yamakawa M; Hansch C; Quinn FR
    Farmaco Sci; 1980 Dec; 35(12):965-79. PubMed ID: 7202703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of butylated hydroxyanisole on adriamycin-induced cardiotoxicity.
    Vora J; Khaw BA; Narula J; Boroujerdi M
    J Pharm Pharmacol; 1996 Sep; 48(9):940-4. PubMed ID: 8910858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
    Doroshow JH
    Cancer Res; 1983 Feb; 43(2):460-72. PubMed ID: 6293697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anthracyclines and mitoxantrone on oxygen uptake and ATP intracellular concentration in rat heart slices.
    Neri B; Cini-Neri G; D'Alterio M
    Biochem Biophys Res Commun; 1984 Dec; 125(3):954-60. PubMed ID: 6596102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.